Al Giza Desert

Researchers are studying the urinary microbiota in adult men with bladder cancer to understand its role in health and disease development, particularly bladder cancer. The study compares the microbiota profiles between male patients with bladder cancer and healthy adult male controls using advanced genomic sequencing techniques. This research aims to contribute to new prevention, diagnosis, and treatment strategies for bladder cancer by analyzing the differences in microbial communities. The study collects urine and bladder tissue samples from male patients diagnosed with either non-muscle invasive or muscle invasive bladder cancer and from healthy controls. Each patient with bladder cancer provides both urine and tissue samples, while control participants provide urine samples only. These samples are analyzed using whole genomic sequencing and 16S ribosomal RNA gene sequencing to profile the microbiota. The samples are processed and stored under strict conditions before sequencing, and the resulting data undergo bioinformatics and statistical analyses to identify microbial differences between groups. Participants provide clinical information and samples during standard diagnostic procedures such as cystoscopy and tumor resection. The study assesses microbial composition in these samples and correlates findings with clinical and pathological data. Researchers monitor and analyze the microbiota over a two-year period to characterize its features in bladder cancer. The total participation involves providing samples during clinical visits, with no additional treatment or intervention. The studys primary outcome is to characterize the urinary microbiota in male patients with bladder cancer.